
According to data from Benzinga Pro, during Q4, Apyx Medical's (NASDAQ:APYX) reported sales totaled $16.82 million. Despite a 52.53% increase in earnings, the company posted a loss of $2.01 million. In Q3, Apyx Medical brought in $11.83 million in sales but lost $4.23 million in earnings.